Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Evaluating deep learning for enhanced breast cancer diagnosis: a comparative analysis of CNN architectures

Artificial Intelligence (AI), particularly its machine learning (ML) subfield, has revolutionised various sectors, including healthcare. In breast cancer care, AI's ability to analyse vast datasets and extract complex patterns from medical images has the potential to transform diagnostics and treatm...

Full description

Saved in:
Bibliographic Details
Main Author: Frankle, Solyle
Other Authors: Sinkala, Musalula
Format: Thesis
Language:English
English
Published: Division of Chemical and Systems Biology 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613274100465664
access_status_str Open Access
author Frankle, Solyle
author2 Sinkala, Musalula
author_browse Frankle, Solyle
Sinkala, Musalula
author_facet Sinkala, Musalula
Frankle, Solyle
author_sort Frankle, Solyle
collection Thesis
description Artificial Intelligence (AI), particularly its machine learning (ML) subfield, has revolutionised various sectors, including healthcare. In breast cancer care, AI's ability to analyse vast datasets and extract complex patterns from medical images has the potential to transform diagnostics and treatment strategies. Breast cancer remains one of the most prevalent cancers affecting women globally, with early and accurate diagnosis being crucial for effective treatment. AI, through its advanced image analysis capabilities, significantly improves the accuracy and efficiency of breast cancer diagnosis, specifically in distinguishing between cancer subtypes. Here, we aim to explore the application of deep learning, particularly convolutional neural networks (CNNs), in breast cancer subtype classification using histology images. A custom CNN model, alongside well-established models like ResNet50 and EfficientNetB0, was developed and evaluated for its accuracy in predicting benign and malignant breast cancer subtypes. The results demonstrated that while the custom CNN achieved an accuracy of 65% for malignant and 67% for benign subtypes with ROC-AUC scores of 0.86 and 0.90, respectively, ResNet50 significantly outperformed both the custom model and EfficientNetB0. ResNet50 attained an accuracy of 77% in classifying malignant subtypes and 77% for benign subtypes, accompanied by ROC-AUC scores of 0.92 and 0.96, respectively. Additionally, ResNet50 exhibited higher precision (0.68 for malignant, 0.67 for benign), recall (0.65 for malignant, 0.67 for benign), and F1 scores (0.65 for malignant, 0.67 for benign) across most subtypes, underscoring its robust performance and reliability in clinical settings. In conclusion, AI, specifically through advanced CNN architectures, can greatly enhance breast cancer diagnosis by providing more accurate subtype classifications. Future work should focus on integrating these models into clinical workflows, enabling faster and more personalised treatment planning. Moreover, continued refinement of these models, including addressing the complexities of tumour heterogeneity and incorporating multimodal data, will be crucial for their widespread adoption in oncology.
format Thesis
id oai:open.uct.ac.za:11427/42289
institution University of Cape Town (South Africa)
language English
eng
last_indexed 2026-06-10T12:33:31.121Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2025
publishDateRange 2025
publishDateSort 2025
publisher Division of Chemical and Systems Biology
publisherStr Division of Chemical and Systems Biology
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/42289 Evaluating deep learning for enhanced breast cancer diagnosis: a comparative analysis of CNN architectures Frankle, Solyle Sinkala, Musalula Breast Cancer CNN AI Artificial Intelligence (AI), particularly its machine learning (ML) subfield, has revolutionised various sectors, including healthcare. In breast cancer care, AI's ability to analyse vast datasets and extract complex patterns from medical images has the potential to transform diagnostics and treatment strategies. Breast cancer remains one of the most prevalent cancers affecting women globally, with early and accurate diagnosis being crucial for effective treatment. AI, through its advanced image analysis capabilities, significantly improves the accuracy and efficiency of breast cancer diagnosis, specifically in distinguishing between cancer subtypes. Here, we aim to explore the application of deep learning, particularly convolutional neural networks (CNNs), in breast cancer subtype classification using histology images. A custom CNN model, alongside well-established models like ResNet50 and EfficientNetB0, was developed and evaluated for its accuracy in predicting benign and malignant breast cancer subtypes. The results demonstrated that while the custom CNN achieved an accuracy of 65% for malignant and 67% for benign subtypes with ROC-AUC scores of 0.86 and 0.90, respectively, ResNet50 significantly outperformed both the custom model and EfficientNetB0. ResNet50 attained an accuracy of 77% in classifying malignant subtypes and 77% for benign subtypes, accompanied by ROC-AUC scores of 0.92 and 0.96, respectively. Additionally, ResNet50 exhibited higher precision (0.68 for malignant, 0.67 for benign), recall (0.65 for malignant, 0.67 for benign), and F1 scores (0.65 for malignant, 0.67 for benign) across most subtypes, underscoring its robust performance and reliability in clinical settings. In conclusion, AI, specifically through advanced CNN architectures, can greatly enhance breast cancer diagnosis by providing more accurate subtype classifications. Future work should focus on integrating these models into clinical workflows, enabling faster and more personalised treatment planning. Moreover, continued refinement of these models, including addressing the complexities of tumour heterogeneity and incorporating multimodal data, will be crucial for their widespread adoption in oncology. 2025-11-21T06:49:43Z 2025-11-21T06:49:43Z 2025 2025-11-21T06:46:50Z Thesis / Dissertation Masters MSc http://hdl.handle.net/11427/42289 en eng application/pdf Division of Chemical and Systems Biology Faculty of Health Sciences University of Cape Town
spellingShingle Breast Cancer
CNN
AI
Frankle, Solyle
Evaluating deep learning for enhanced breast cancer diagnosis: a comparative analysis of CNN architectures
thesis_degree_str Master's
title Evaluating deep learning for enhanced breast cancer diagnosis: a comparative analysis of CNN architectures
title_full Evaluating deep learning for enhanced breast cancer diagnosis: a comparative analysis of CNN architectures
title_fullStr Evaluating deep learning for enhanced breast cancer diagnosis: a comparative analysis of CNN architectures
title_full_unstemmed Evaluating deep learning for enhanced breast cancer diagnosis: a comparative analysis of CNN architectures
title_short Evaluating deep learning for enhanced breast cancer diagnosis: a comparative analysis of CNN architectures
title_sort evaluating deep learning for enhanced breast cancer diagnosis a comparative analysis of cnn architectures
topic Breast Cancer
CNN
AI
url http://hdl.handle.net/11427/42289
work_keys_str_mv AT franklesolyle evaluatingdeeplearningforenhancedbreastcancerdiagnosisacomparativeanalysisofcnnarchitectures